← Back to headlines
Health Insurers Question Medicare GLP-1 Program, Causing Pharma Stock Drops
Health insurers are raising questions about a new Medicare program that will offer GLP-1 medications to seniors for $50 per month, leading to a drop in shares for pharmaceutical companies like Novo Nordisk and Eli Lilly amid concerns over coverage plans.
21 Apr, 16:11 — 21 Apr, 17:54
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center1
Center (1)
marketwatch
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
marketwatchMostly Factual132d ago
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50
Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for GLP-1 medications for weight loss.
By Jaimy Lee
Read full article →seeking-alphaMixed132d ago
Novo, Lilly drop as insurers are wary of joining Medicare GLP-1 coverage plan
Read full article →Coverage Timeline
First report: seeking-alpha · 21 Apr, 16:11|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
50m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
8h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
10h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
19h ago